Efficacy and safety of intravenous laronidase for mucopolysaccharidosis type I: A systematic review and meta-analysis-Reference-Cited by-同舟云学术

Efficacy and safety of intravenous laronidase for mucopolysaccharidosis type I: A systematic review and meta-analysis

Published:2017-08-31 Issue:8 Volume:12 Page:e0184065
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Dornelles Alícia Dorneles^ORCID,Artigalás Osvaldo,da Silva André Anjos,Ardila Dora Lucia Vallejo,Alegra Taciane,Pereira Tiago Veiga,Vairo Filippo Pinto e,Schwartz Ida Vanessa Doederlein

Funder

Hospital de Clínicas de Porto Alegre

Ministério da Saúde

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference42 articles.

1. The Online Metabolic and Molecular Bases of Inherited Disease;EF Neufeld,2014

2. Prevalence of lysosomal storage disorders;PJ Meikle;JAMA,1999

3. The prevalence of and survival in Mucopolysaccharidosis I: Hurler, Hurler-Scheie and Scheie syndromes in the UK;D Moore;Orphanet J Rare Dis,2008

4. Pilot study of newborn screening for six lysosomal storage diseases using Tandem Mass Spectrometry;S Elliott;Mol Genet Metab,2016

5. Lysosomal storage disorder screening implementation: findings from the first six months of full population pilot testing in Missouri;PV Hopkins;J Pediatr,2015

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mucopolysaccharidosis type I Hurler-Scheie syndrome: a case report;Annals of Medicine & Surgery;2023-11-27

2. Glycosylation shapes the efficacy and safety of diverse protein, gene and cell therapies;Biotechnology Advances;2023-10

3. Advances in therapies for neurological lysosomal storage disorders;Journal of Inherited Metabolic Disease;2023-05-02

4. Mucopolysaccharidosis Type I in Mexico: Case-Based Review;Children;2023-03-30

5. Expression of Long Noncoding RNAs in Fibroblasts from Mucopolysaccharidosis Patients;Genes;2023-01-20